がん抑制遺伝子治療の世界市場及びパイプラインインサイト...市場調査レポートについてご紹介

【英文タイトル】Oncogene Inhibitors Therapy Market & Pipeline Insight 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Introduction to Oncogene Inhibitors

2. Mechanism of Oncogene Inhibitors

3. Global Oncogene Inhibitors Market Overview
3.1 Current Market Scenario
3.2 Oncogene Inhibitors Clinical Pipeline Insight

4. Global Oncogene Inhibitor Market Dynamics
4.1 Favorable Market Parameters
4.2 Commercialization Challenges

5. Global Oncogene Inhibitor Market Future Prospects

6. Oncogene Protein Inhibitors Pipeline by Company, Indication & Phase
6.1 Preclinical
6.2 Suspended & Discontinued

7. Proto-Oncogene Protein c-bcl-2 Inhibitors Pipeline by Company, Indication & Phase
7.1 Research till Preregistration
7.2 Marketed Drug Clinical Insight
7.3 Suspended & Discontinued

8. Proto Oncogene Protein b raf Inhibitors Pipeline by Company, Indication & Phase
8.1 Research till Phase-III
8.2 Marketed Drug Clinical Insight
8.3 Suspended & Discontinued

9. Proto Oncogene Protein c-kit Inhibitors Pipeline by Company, Indication & Phase
9.1 Research till Preregistration
9.2 Marketed Drug Clinical Insight
9.3 Suspended & Discontinued

10. Proto-Oncogene Protein c-rel Inhibitors Pipeline by Company, Indication & Phase
10.1 Research

11. Proto Oncogene Protein c-akt Inhibitors Pipeline by Company, Indication & Phase
11.1 Preclinical till Phase-III
11.2 Suspended & Discontinued

12. Proto Oncogene Protein c met Inhibitors Pipeline by Company, Indication & Phase
12.1 Preclinical till Phase-III
12.2 Marketed Drug Clinical Insight
12.3 Suspended & Discontinued

13. Proto Oncogene Protein c ret Inhibitors Pipeline by Company, Indication & Phase
13.1 Preclinical till Phase-III
13.2 Marketed Drug Clinical Insight
13.3 Suspended & Discontinued

14. Proto-Oncogene Protein c mdm2 Inhibitors Pipeline by Company, Indication & Phase
14.1 Preclinical till Phase-I/II
14.2 Suspended & Discontinued

15. Proto-Oncogene Protein Inhibitors Pipeline by Company, Indication & Phase
15.1 Preclinical

16. Proto-Oncogene-Protein-c-ets Inhibitors Pipeline by Company, Indication & Phase
16.1 Preclinical

17. Proto-Oncogene Protein c-fli-1 Inhibitors Pipeline by Company, Indication & Phase
17.1 Preclinical

18. Proto Oncogene Proteins c pim 1 Inhibitors Pipeline by Company, Indication & Phase
18.1 Preclinical till Phase-I/II
18.2 Suspended & Discontinued

19. Proto Oncogene Protein c-myc Inhibitors Pipeline by Company, Indication & Phase
19.1 Preclinical till Phase-I/II
19.2 Marketed Drug Clinical Insight

20. Proto Oncogene Proteins c raf Inhibitors Pipeline by Company, Indication & Phase
20.1 Suspended & Discontinued

21. Proto Oncogene Proteins c myb Inhibitors Pipeline by Company, Indication & Phase

22. Multiple Oncogene Inhibitors Pipeline by Company, Indication & Phase
22.1 Preclinical till Registered
22.2 Marketed Drug Clinical Insight
22.3 Suspended & Discontinued

23. Competitive Landscape
23.1 AstraZeneca
23.2 ArQule Inc
23.3 Biogen Idec
23.4 Boehringer Ingelheim
23.5 Celgene Corporation
23.6 Constellation Pharmaceutical
23.7 Epizyme Pharmaceutical
23.8 Genentech
23.9 GalaxoSmithKline
23.10 Incyte Corporation
23.11 Johnson & Johnson
23.12 Merck
23.13 Novartis
23.14 Onyx pharmaceuticals
23.15 Pfizer


【レポート販売概要】

■ タイトル:がん抑制遺伝子治療の世界市場及びパイプラインインサイト
■ 英文:Oncogene Inhibitors Therapy Market & Pipeline Insight 2015
■ 発行日:2015年4月
■ 調査会社:KuicK Research
■ 商品コード:KUICK504091
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。